Year archive

ALGORAE PHARMACEUTICALS LIMITED — 2012 filings

All 46 regulatory filings released by ALGORAE PHARMACEUTICALS LIMITED (1AI) in 2012, sourced directly from the official regulator.

46 Filings

2012 Period

2012 filings (46)

Filing	Released	Lang
LCT & Otsuka to co-develop NTCELL for Parkinson's Disease 3 pages 123.4KB Capital/Financing Update	2012-12-16	English
Open Briefing interview with MD and CEO Andrea Grant 4 pages 245.6KB Capital/Financing Update	2012-12-16	English
LCT appoints Chief Science and Medical Officer 3 pages 49.6KB Board/Management Information	2012-12-09	English
Strong interim results in Argentinian DIABECELL trial 3 pages 53.9KB Interim / Quarterly Report	2012-11-21	English
LCT starts DIABECELL Phase IIb trial in Argentina 2 pages 48.9KB Regulatory Filings	2012-11-21	English
Alteration to issued capital 4 pages 80.0KB Regulatory Filings	2012-11-19	English
Initial Director's Interest Notice 2 pages 30.4KB Director's Dealing	2012-11-18	English
Ethical approval for LCT's NTCELL Phase I trial 2 pages 42.5KB Regulatory Filings	2012-11-15	English
LCT CEO Dr Andrea Grant appointed Managing Director 2 pages 44.1KB Board/Management Information	2012-11-15	English
Chairman's Address to the 2012 Annual General Meeting 2 pages 42.7KB AGM Information	2012-11-15	English
AGM Presentation 24 pages 850.7KB AGM Information	2012-11-15	English
Results of 2012 Annual General Meeting 2 pages 30.0KB Declaration of Voting Results & Voting Rights Announcements	2012-11-15	English
Change of Director's Interest Notice 2 pages 74.7KB Director's Dealing	2012-11-04	English
Six reasons to invest in LCT 11 pages 4.1MB Investor Presentation	2012-11-01	English
Appendix 4C - quarterly 7 pages 101.6KB Interim / Quarterly Report	2012-10-29	English
Notice of Annual General Meeting/Proxy Form 7 pages 93.9KB AGM Information	2012-10-14	English
Annual Report to shareholders 60 pages 3.3MB Regulatory Filings	2012-10-14	English
Authorisation of Ph1 trial of NTCell in Parkinsons Disease 3 pages 27.9KB Regulatory Filings	2012-10-03	English
Form 492 3 pages 85.4KB Regulatory Filings	2012-10-02	English
Change of Director's Interest Notice 2 pages 73.6KB Director's Dealing	2012-09-27	English
LCT announces positive DIABECELL Phase I/IIa trial 11 pages 1.9MB Regulatory Filings	2012-09-25	English
Preliminary Final Report for the year ended 30 June 2012 70 pages 782.4KB Annual Report	2012-08-28	English
Change of Director's Interest Notice 2 pages 74.7KB Director's Dealing	2012-08-16	English
Change of Director's Interest Notice 2 pages 72.2KB Director's Dealing	2012-08-05	English
Change of Director's Interest Notice 2 pages 73.6KB Director's Dealing	2012-07-23	English
Appendix 4C - quarterly 7 pages 104.1KB Interim / Quarterly Report	2012-07-22	English
Change of Director`s Interest Notice 2 pages 72.0KB Director's Dealing	2012-06-05	English
LCT restructures for next stage of growth 2 pages 209.6KB Board/Management Information	2012-05-31	English
LCT`s DIABECELL trial extension approved 2 pages 45.1KB Regulatory Filings	2012-05-16	English
Change of Director`s Interest Notice 2 pages 72.8KB Director's Dealing	2012-05-03	English
Appendix 3B 7 pages 71.6KB Capital/Financing Update	2012-05-02	English
Cleansing Statement 1 page 23.1KB Regulatory Filings	2012-05-02	English
LCT`s Share Purchase Plan successful 2 pages 28.2KB Capital/Financing Update	2012-04-30	English
Appendix 4C - quarterly 7 pages 59.2KB Interim / Quarterly Report	2012-04-29	English
Dr Barry Snow to lead Parkinson`s trial for LCT 3 pages 36.0KB Regulatory Filings	2012-04-16	English
Share Purchase Plan documents mailed to Shareholders 8 pages 125.2KB Capital/Financing Update	2012-03-29	English
LCT Presents Novel Parkinson`s Disease Treatment Results 2 pages 36.8KB Regulatory Filings	2012-03-20	English
LCT announces Share Purchase Plan 2 pages 47.3KB Capital/Financing Update	2012-03-19	English
Half Yearly Report and Accounts 24 pages 781.7KB Interim / Quarterly Report	2012-02-27	English
LCT completes pre-clinical studies of NTCELL in Parkinson`s 2 pages 36.1KB Regulatory Filings	2012-02-27	English
LCT granted E.U. Patent for tissue engineering 2 pages 35.8KB Regulatory Filings	2012-02-27	English
Price query response 3 pages 93.1KB Regulatory Filings	2012-02-15	English
LCT granted USA Patent for Auckland Island Pigs 3 pages 38.2KB Regulatory Filings	2012-02-01	English
Becoming a substantial holder 16 pages 447.0KB Regulatory Filings	2012-01-29	English
Change in substantial holding 16 pages 448.1KB Regulatory Filings	2012-01-29	English
Appendix 4C - quarterly 7 pages 115.3KB Interim / Quarterly Report	2012-01-26	English

Filings by year

2026 42 filings
2025 46 filings
2024 50 filings
2023 53 filings
2022 61 filings
2021 61 filings
2020 20 filings
2019 33 filings
2018 32 filings
2017 40 filings
2016 54 filings
2015 38 filings
2014 44 filings
2013 33 filings
2012 46 filings
2011 78 filings
2010 63 filings
2009 65 filings
2008 55 filings
2007 78 filings
2006 69 filings
2005 48 filings
2004 50 filings